The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.
Clinical trial NCT03619044 · TERMINATED
Trial details
- NCT number
- NCT03619044
- Sponsor
- Institut Claudius Regaud
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-28
- Primary completion
- 2021-06-11
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.